Aparna Kalyan

Personal profile

Research Interests

My primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. I am interested in incorporating immunotherapy and molecular testing into clinical trials.

Training Experience

2009	Residency, St. Vincents Hospital, Melbourne Australia
2011	Residency, University Hospitals Case Medical Center, Cleveland OH
2014	Fellowship, University of Pittsburgh Medical Center
2014	Fellowship, Northwestern University

Education/Academic qualification

MBBS, Flinders University

… → 2005

Research interests

Cancer Biology
Colon / Rectal Cancer
Nanotechnology
Pancreatic Cancer

Fingerprint Dive into the research topics where Aparna Kalyan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

3 Finished
4 Active

Prot #H3B-6527-G000-101: An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Kalyan, A.

PPD Investigator Services, LLC, H3 Biomedicine Inc.

2/14/18 → 2/14/21

Project: Research project

Prot #AG120-C-005: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation

Kalyan, A.

DrugDev Inc., Agios Pharmaceuticals, Inc.

1/25/18 → 1/25/21

Project: Research project

Prot #NC-6004-004A: A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine in Patients with Advanced Solid Tumors or Squamous Non-Small Cell Lung, Biliary Tract, and Bladder Cancer

Kalyan, A.

PPD Investigator Services, LLC, NanoCarrier Co., Ltd.

8/29/17 → 8/29/20

Project: Research project

Prot #D419NC00001: A Phase 1 Study of Durvalumab and IPH2201 in Adult Subjects with Select Advanced Solid Tumors

Carneiro Filho, B. A., Chae, Y. K. & Kalyan, A.

MedImmune, LLC

2/6/17 → 2/6/23

Project: Research project

Prot #ABI-007-PANC-009: An Open-Label, Multicenter, Single-Arm, Phase 1/2 Study Of Metronomic 5-Fluorouracil In Combination With Nabpaclitaxel, Bevacizumab, Leucovorin, And Oxaliplatin In Patients With Metastatic Pancreatic Adenocarcinoma

Kalyan, A.

INC Research, LLC, Celgene Corporation

8/10/16 → 8/10/19

Project: Research project